Diminishing apoptosis by deletion of bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo
Artículo

Open/ Download
Access note
Acceso Abierto
Publication date
2007Metadata
Show full item record
Cómo citar
Steele, Andrew D.
Cómo citar
Diminishing apoptosis by deletion of bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo
Author
Abstract
B-cell lymphoma protein 2 (Bcl-2) and Bcl-2-associated X protein (Bax), key antiapoptotic and proapoptotic proteins, respectively, have important roles in acute and chronic models of neurologic disease. Several studies have implicated Bax and Bcl-2 in mediating neurotoxicity in prion diseases. To determine whether diminishing apoptotic cell death is protective in an infectious prion disease model we inoculated mice that either were null for proapoptotic Bax or overexpressed antiapoptotic Bcl-2. Interestingly, genetic manipulation of apoptosis did not lessen the clinical severity of disease. Moreover, some disease parameters, such as behavioral alterations and death, occurred slightly earlier in mice that are null for Bax or overexpress Bcl-2. These results suggest that Bax and Bcl-2 mediated apoptotic pathways are not the major contributing factor to the clinical or pathological features of infectious prion disease. Copyright © 2007 Society for Neuroscience.
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/164430
DOI: 10.1523/JNEUROSCI.3290-07.2007
ISSN: 02706474
02706474
Quote Item
Journal of Neuroscience, Volumen 27, Issue 47, 2018, Pages 13022-13027
Collections